WHO IS DR. SUZANNE FERREE?

Double board-certified physician, Navy veteran, and expert in peptide therapy, anti-aging, and regenerative medicine. Author of Counterclockwise, redefining longevity.

Dr. Ferree breaks down how peptides transform biohacking, why most aren't ready for advanced therapies, and the foundation needed before HRT or peptides from injury healing to reversing age-related decline.

WHO IS DR. SUZANNE FERREE?

Double board-certified physician, Navy veteran, and expert in peptide therapy, anti-aging, and regenerative medicine. Author of Counterclockwise, redefining longevity.

Dr. Ferree breaks down how peptides transform biohacking, why most aren't ready for advanced therapies, and the foundation needed before HRT or peptides from injury healing to reversing age-related decline.

WHO IS DR. SUZANNE FERREE?

Double board-certified physician, Navy veteran, and expert in peptide therapy, anti-aging, and regenerative medicine. Author of Counterclockwise, redefining longevity.

Dr. Ferree breaks down how peptides transform biohacking, why most aren't ready for advanced therapies, and the foundation needed before HRT or peptides from injury healing to reversing age-related decline.

WHO IS DR. DREW TAYLOR?

Biotech scientist & founder of Acorn Biolabs, Dr. Drew Taylor leads personalized regenerative medicine by preserving your own cells and extracting the Secretome—healing signals for recovery, longevity & aesthetics.

Stem cells aren’t the magic—their signals are. In Part 1, Dr. Drew breaks down the Secretome: growth factors & exosomes from your own cells, delivering stem-cell benefits with a safer, personalized approach.

Chapters

00:00 Personalized regen vision

01:37 Why genetics matter

03:30 Donor stem risks

05:23 Third-gen regen

07:10 Cells as currency

09:22 Bank cells for life

12:45 Cost vs clinics

16:47 Why Acorn is unique

WHO IS DR. DREW TAYLOR?

Biotech scientist & founder of Acorn Biolabs, Dr. Drew Taylor leads personalized regenerative medicine by preserving your own cells and extracting the Secretome—healing signals for recovery, longevity & aesthetics.

Stem cells aren’t the magic—their signals are. In Part 1, Dr. Drew breaks down the Secretome: growth factors & exosomes from your own cells, delivering stem-cell benefits with a safer, personalized approach.

Chapters 00:00 Stem cell aging 01:37 Why “from you” works 03:30 Stem cells & decline 05:23 Aging is exponential 07:10 Skin, hair & inflammation 09:22 Aesthetics & recovery 12:45 Secretome vs PRP 16:47 FDA path & future use

WHO IS DR. DREW TAYLOR?

Biotech scientist & founder of Acorn Biolabs, Dr. Drew Taylor leads personalized regenerative medicine by preserving your own cells and extracting the Secretome—healing signals for recovery, longevity & aesthetics.

Stem cells aren’t the magic—their signals are. In Part 1, Dr. Drew breaks down the Secretome: growth factors & exosomes from your own cells, delivering stem-cell benefits with a safer, personalized approach.

Chapters

00:00 Why stem cells don’t heal

01:37 Meet Dr. Drew Taylor

03:30 What the Secretome is

05:23 FedEx analogy

07:10 Proof it works

09:22 Why stem cells fail

12:45 Safety of “from you”

16:47 Non-invasive capture

WHO IS SHALIN SHAH?

Founder, CEO, and visionary behind Marius Pharmaceuticals, the company that brought Kyzatrex to market—the first FDA-approved oral testosterone replacement therapy. With a background in private equity and investing, he moved into biotech to solve a long-standing problem in hormone health: making testosterone therapy more accessible, more practical, and aligned with modern lifestyles—while supporting education, stigma reduction, and better men’s health outcomes.

In this two-part roundtable, the Biohacking Brothers sit down with Shalin Shah to break down why testosterone is a foundational longevity hormone, how Kyzatrex became the first FDA-approved oral testosterone, and what makes oral pulsatile dosing different from traditional injections.

They cover cardiovascular and cognitive implications, stigma and access, fertility concerns, SHBG and free testosterone, estrogen myths, safety markers like hematocrit, and why patient education and proper lab interpretation matter—especially in a world where testosterone levels are declining across younger men.

WHO IS SHALIN SHAH?

Founder, CEO, and visionary behind Marius Pharmaceuticals, the company that brought Kyzatrex to market—the first FDA-approved oral testosterone replacement therapy. With a background in private equity and investing, he moved into biotech to solve a long-standing problem in hormone health: making testosterone therapy more accessible, more practical, and aligned with modern lifestyles—while supporting education, stigma reduction, and better men’s health outcomes.

In this two-part roundtable, the Biohacking Brothers sit down with Shalin Shah to break down why testosterone is a foundational longevity hormone, how Kyzatrex became the first FDA-approved oral testosterone, and what makes oral pulsatile dosing different from traditional injections.

They cover cardiovascular and cognitive implications, stigma and access, fertility concerns, SHBG and free testosterone, estrogen myths, safety markers like hematocrit, and why patient education and proper lab interpretation matter—especially in a world where testosterone levels are declining across younger men.